Reynolds asks FDA to give Camel Snus products ‘modified risk’ status

R. J. Reynolds has submitted modified risk tobacco product applications (MRTPAs) to the US FDA for six forms of its Camel Snus product, which it is seeking to market as reducing the risk of specific smoking-related diseases ...

Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik